MCCB Postdoc Achievements
Postdocs mentored by MCCB faculty have been successful in publishing high-impact papers, securing fellowships, and obtaining positions in academics and industry.
Publications
Click to expand/contract
In the following is a list of selected recent postdoc-led peer-reviewed research publications, the postdoc’s name is in bold and the faculty advisor’s name is underlined.
P21-positive senescence stromal cells promote prostate cancer immune suppression and progression that can be reversed by senolytic therapy.
Zhou L, DeMarco KD, Murphy KC, Wu Z, Li J, Johnson C, Liu B, Giwa HK, Ma B, Bhalerao N, Li J, Jiang Z, Bai S, Parikh CN, Ye T, Simin K, Zhu LJ, Pitarresi JR, Wu H, Ruscetti M. Cancer Discov. 2025 Oct 27. doi: 10.1158/2159-8290.CD-25-1212. Online ahead of print.
PPT1 is a negative regulator of STING signaling in cancer cells and its inhibition reactivates immune surveillance in cold tumors.
Chowdhury SR, Parikh CN, Kaur AN, DeMarco KD, Giwa HK, Mishra AK, Murphy KC, Zhou L, Ma B, Ye T, Li J, Liu H, Bai S, Johnson C, Simin K, Pitarresi JR, Zhu LJ, Watson EV, Kelliher MA, Green MR, Fitzgerald KA, Ruscetti M. Proc Natl Acad Sci USA. 2025 Sep 30;122(39):e2514948122.
Dynamic phosphorylation of Hcm1 promotes fitness in chronic stress.
Conti MM, Vail JP, Reynolds AR, Budge LG, Flynn MJ, Li R, Zhu LJ, Benanti JA. PLoS Genet. 2025 Sep 15;21(9):e1011874.
Microglia promote inflammatory cell death upon neuronal mitochondrial impairment during neurodegeneration.
Miao G, Fortier TM, Liu H, Schafer DP, Fitzgerald KA, Mao J and Baehrecke EH. Nat Struct Mol Biol. 2025 Jun 25;online ahead of print.
Targeting BRCA1-deficient PARP inhibitor-resistant cells with nickases reveals nick resection as a cancer vulnerability.
Whalen JM, Earley J, Wisniewski C, Mercurio AM, Cantor SB. Nat Cancer. 2025 Jan 21;6(2):278-291.
Therapeutic induction of ferroptosis in tumors using PD-L1 targeting antibody nanogel conjugates.
Wang M, Prachyathipsakul T, Wisniewski CA, Xiong C, Goel S, Goel HL, Karner ER, Mukhopadhyay D, Gupta P, Majee A, Thayumanavan S, Mercurio AM. Cell Chem Biol. 2024 Dec 19;31(12):2039-2051.
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer.
Chibaya L, DeMarco KD, Lusi CF, Kane GI, Brassil ML, Parikh CN, Murphy KC, Chowdhury SR, Li J, Ma B, Naylor TE, Cerrutti J, Mori H, Diaz-Infante M, Peura J, Pitarresi JR, Zhu LJ, Fitzgerald KA, Atukorale PU, Ruscetti M. Sci Transl Med. 2024 Aug 28;16(762):eadj9366.
Selenium reduction of ubiquinone via SQOR suppresses ferroptosis.
Lee N, Park SJ, Lange M, Tseyang T, Doshi MB, Kim TY, Song Y, Kim DI, Greer PL, Olzmann JA, Spinelli JB, Kim D. Nat Metab. 2024 Feb;6(2):343-358.
Fellowships
Click to expand/contract
| Postdoc | Faculty advisor | Fellowship | Years |
| Jenna Whalen, PhD | Sharon Cantor |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32): Mapping the BRCA2 replication gap suppression domain to uncover the molecular mechanism of chemotherapy response |
2023-2026 |
| Sneha Gopalan, PhD | Tom Fazzio |
NIH Pathway to Independence Award (K99/R00): Single cell chromatin profiling to study epigenetic alterations of ovarian tumors |
2022-2024 |
| Mengdie Wang, PhD | Art Mercurio |
U.S. Department of Defense Congressionally Directed Medical Research Program, Prostate Cancer Research Program: Targeted inhibition of neuropilin-2 to enhance immunotherapy of lethal prostate cancer |
2021-2023 |
| Reem Suleiman, PhD | Michelle Kelliher | American Association of Immunologists Fellowship for Career Reentry | 2021-2022 |